Rosenblatt Maintains Buy on Imax, Maintains $25 Price Target
Portfolio Pulse from Benzinga Newsdesk
Rosenblatt analyst Steve Frankel maintains a Buy rating on Imax (NYSE:IMAX) with a $25 price target.
June 17, 2024 | 12:41 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Rosenblatt analyst Steve Frankel has reiterated a Buy rating on Imax (NYSE:IMAX) and maintained a price target of $25.
The reiteration of a Buy rating and a $25 price target by a reputable analyst is likely to positively impact investor sentiment and could lead to a short-term increase in IMAX's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100